Annual CFO
-$160.34 M
+$40.20 M+20.05%
31 December 2023
Summary:
Centessa Pharmaceuticals annual cash flow from operations is currently -$160.34 million, with the most recent change of +$40.20 million (+20.05%) on 31 December 2023. During the last 3 years, it has fallen by -$149.71 million (-1408.39%). CNTA annual CFO is now -2652.65% below its all-time high of -$5.83 million, reached on 31 December 2019.CNTA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$21.39 M
+$19.19 M+47.29%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly cash flow from operations is currently -$21.39 million, with the most recent change of +$19.19 million (+47.29%) on 30 September 2024. Over the past year, it has increased by +$16.00 million (+42.80%). CNTA quarterly CFO is now at all-time high.CNTA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$130.31 M
+$16.00 M+10.94%
30 September 2024
Summary:
Centessa Pharmaceuticals TTM cash flow from operations is currently -$130.31 million, with the most recent change of +$16.00 million (+10.94%) on 30 September 2024. Over the past year, it has increased by +$50.55 million (+27.95%). CNTA TTM CFO is now -160.52% below its all-time high of -$50.02 million, reached on 31 March 2022.CNTA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.1% | +42.8% | +27.9% |
| 3 y3 years | -1408.4% | - | - |
| 5 y5 years | - | - | - |
CNTA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1408.4% | +20.1% | at high | +64.3% | -160.5% | +35.0% |
| 5 y | 5 years | -2652.7% | +20.1% | at high | +64.3% | -160.5% | +35.0% |
| alltime | all time | -2652.7% | +20.1% | at high | +64.3% | -160.5% | +35.0% |
Centessa Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.39 M(-47.3%) | -$130.31 M(-10.9%) |
| June 2024 | - | -$40.58 M(+8.8%) | -$146.31 M(-2.3%) |
| Mar 2024 | - | -$37.29 M(+20.1%) | -$149.79 M(-6.6%) |
| Dec 2023 | -$160.34 M | -$31.05 M(-17.0%) | -$160.34 M(-11.3%) |
| Sept 2023 | - | -$37.39 M(-15.1%) | -$180.86 M(-0.9%) |
| June 2023 | - | -$44.06 M(-7.9%) | -$182.55 M(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$47.84 M(-7.2%) | -$198.37 M(-1.1%) |
| Dec 2022 | -$200.55 M(+1786.6%) | -$51.56 M(+31.9%) | -$200.55 M(+34.6%) |
| Sept 2022 | - | -$39.09 M(-34.7%) | -$148.98 M(+35.6%) |
| June 2022 | - | -$59.88 M(+19.7%) | -$109.89 M(+119.7%) |
| Mar 2022 | - | -$50.02 M | -$50.02 M |
| Dec 2020 | -$10.63 M(+82.5%) | - | - |
| Dec 2019 | -$5.83 M | - | - |
FAQ
- What is Centessa Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual CFO year-on-year change?
- What is Centessa Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly CFO year-on-year change?
- What is Centessa Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM CFO year-on-year change?
What is Centessa Pharmaceuticals annual cash flow from operations?
The current annual CFO of CNTA is -$160.34 M
What is the all time high annual CFO for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual cash flow from operations is -$5.83 M
What is Centessa Pharmaceuticals annual CFO year-on-year change?
Over the past year, CNTA annual cash flow from operations has changed by +$40.20 M (+20.05%)
What is Centessa Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CNTA is -$21.39 M
What is the all time high quarterly CFO for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly cash flow from operations is -$21.39 M
What is Centessa Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CNTA quarterly cash flow from operations has changed by +$16.00 M (+42.80%)
What is Centessa Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CNTA is -$130.31 M
What is the all time high TTM CFO for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM cash flow from operations is -$50.02 M
What is Centessa Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CNTA TTM cash flow from operations has changed by +$50.55 M (+27.95%)